Your institution may have access to this item. Find your institution then sign in to continue.
Title
In this issue.
Abstract
The article discusses various reports published within the issue, including one about several approaches in identifying preclinical safety liabilities in drug discovery process and another about the challenges and opportunities for stem-cell technology in drug discovery.